Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: Q4QIV0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.383 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.383 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.382 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.479 |
CLV_PCSK_KEX2_1 | 19 | 21 | PF00082 | 0.351 |
CLV_PCSK_PC1ET2_1 | 11 | 13 | PF00082 | 0.434 |
CLV_PCSK_PC1ET2_1 | 167 | 169 | PF00082 | 0.526 |
CLV_PCSK_PC1ET2_1 | 19 | 21 | PF00082 | 0.384 |
DOC_MAPK_DCC_7 | 125 | 134 | PF00069 | 0.396 |
DOC_MAPK_MEF2A_6 | 125 | 134 | PF00069 | 0.435 |
DOC_MAPK_MEF2A_6 | 199 | 208 | PF00069 | 0.498 |
DOC_MAPK_MEF2A_6 | 53 | 62 | PF00069 | 0.483 |
DOC_MAPK_NFAT4_5 | 199 | 207 | PF00069 | 0.514 |
DOC_PP1_RVXF_1 | 154 | 161 | PF00149 | 0.620 |
DOC_PP2B_PxIxI_1 | 55 | 61 | PF00149 | 0.306 |
DOC_PP4_FxxP_1 | 93 | 96 | PF00568 | 0.643 |
DOC_USP7_MATH_2 | 96 | 102 | PF00917 | 0.463 |
DOC_WW_Pin1_4 | 151 | 156 | PF00397 | 0.508 |
DOC_WW_Pin1_4 | 47 | 52 | PF00397 | 0.661 |
LIG_14-3-3_CanoR_1 | 114 | 123 | PF00244 | 0.497 |
LIG_14-3-3_CanoR_1 | 159 | 165 | PF00244 | 0.640 |
LIG_Actin_WH2_2 | 146 | 161 | PF00022 | 0.508 |
LIG_APCC_ABBA_1 | 214 | 219 | PF00400 | 0.260 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.621 |
LIG_BRCT_BRCA1_1 | 153 | 157 | PF00533 | 0.576 |
LIG_Clathr_ClatBox_1 | 215 | 219 | PF01394 | 0.346 |
LIG_deltaCOP1_diTrp_1 | 75 | 82 | PF00928 | 0.247 |
LIG_eIF4E_1 | 137 | 143 | PF01652 | 0.353 |
LIG_FAT_LD_1 | 200 | 208 | PF03623 | 0.528 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.349 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.688 |
LIG_FHA_1 | 50 | 56 | PF00498 | 0.588 |
LIG_LIR_Apic_2 | 117 | 123 | PF02991 | 0.455 |
LIG_LIR_Gen_1 | 154 | 164 | PF02991 | 0.727 |
LIG_LIR_Gen_1 | 181 | 192 | PF02991 | 0.596 |
LIG_LIR_Gen_1 | 31 | 42 | PF02991 | 0.643 |
LIG_LIR_Gen_1 | 75 | 84 | PF02991 | 0.239 |
LIG_LIR_Gen_1 | 87 | 96 | PF02991 | 0.291 |
LIG_LIR_Gen_1 | 97 | 107 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 154 | 160 | PF02991 | 0.685 |
LIG_LIR_Nem_3 | 181 | 187 | PF02991 | 0.595 |
LIG_LIR_Nem_3 | 31 | 37 | PF02991 | 0.641 |
LIG_LIR_Nem_3 | 75 | 79 | PF02991 | 0.247 |
LIG_LIR_Nem_3 | 87 | 91 | PF02991 | 0.287 |
LIG_LIR_Nem_3 | 97 | 102 | PF02991 | 0.463 |
LIG_NRBOX | 199 | 205 | PF00104 | 0.528 |
LIG_NRBOX | 58 | 64 | PF00104 | 0.353 |
LIG_SH2_CRK | 120 | 124 | PF00017 | 0.431 |
LIG_SH2_NCK_1 | 120 | 124 | PF00017 | 0.471 |
LIG_SH2_PTP2 | 137 | 140 | PF00017 | 0.380 |
LIG_SH2_PTP2 | 152 | 155 | PF00017 | 0.408 |
LIG_SH2_SRC | 34 | 37 | PF00017 | 0.665 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.336 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.319 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.415 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.641 |
LIG_SH3_3 | 62 | 68 | PF00018 | 0.345 |
LIG_SUMO_SIM_anti_2 | 198 | 204 | PF11976 | 0.576 |
LIG_SUMO_SIM_anti_2 | 33 | 39 | PF11976 | 0.639 |
LIG_TYR_ITIM | 135 | 140 | PF00017 | 0.370 |
LIG_TYR_ITIM | 215 | 220 | PF00017 | 0.398 |
LIG_WRC_WIRS_1 | 85 | 90 | PF05994 | 0.295 |
MOD_CDC14_SPxK_1 | 50 | 53 | PF00782 | 0.632 |
MOD_CDK_SPK_2 | 151 | 156 | PF00069 | 0.508 |
MOD_CDK_SPxK_1 | 47 | 53 | PF00069 | 0.644 |
MOD_CK1_1 | 101 | 107 | PF00069 | 0.377 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.656 |
MOD_CK2_1 | 2 | 8 | PF00069 | 0.613 |
MOD_Cter_Amidation | 165 | 168 | PF01082 | 0.447 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.439 |
MOD_GSK3_1 | 45 | 52 | PF00069 | 0.670 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.642 |
MOD_N-GLC_1 | 108 | 113 | PF02516 | 0.295 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.711 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.405 |
MOD_NEK2_1 | 91 | 96 | PF00069 | 0.472 |
MOD_PKA_2 | 113 | 119 | PF00069 | 0.516 |
MOD_PKA_2 | 158 | 164 | PF00069 | 0.631 |
MOD_PKA_2 | 169 | 175 | PF00069 | 0.687 |
MOD_PKA_2 | 45 | 51 | PF00069 | 0.635 |
MOD_PKB_1 | 168 | 176 | PF00069 | 0.655 |
MOD_Plk_1 | 108 | 114 | PF00069 | 0.232 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.201 |
MOD_Plk_4 | 54 | 60 | PF00069 | 0.363 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.331 |
MOD_ProDKin_1 | 151 | 157 | PF00069 | 0.511 |
MOD_ProDKin_1 | 47 | 53 | PF00069 | 0.659 |
TRG_DiLeu_BaEn_1 | 198 | 203 | PF01217 | 0.616 |
TRG_DiLeu_BaEn_4 | 195 | 201 | PF01217 | 0.665 |
TRG_DiLeu_BaLyEn_6 | 127 | 132 | PF01217 | 0.457 |
TRG_DiLeu_BaLyEn_6 | 232 | 237 | PF01217 | 0.462 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.342 |
TRG_ENDOCYTIC_2 | 184 | 187 | PF00928 | 0.599 |
TRG_ENDOCYTIC_2 | 217 | 220 | PF00928 | 0.399 |
TRG_ENDOCYTIC_2 | 34 | 37 | PF00928 | 0.641 |
TRG_Pf-PMV_PEXEL_1 | 40 | 44 | PF00026 | 0.471 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBC2 | Leptomonas seymouri | 66% | 100% |
A0A0S4JA41 | Bodo saltans | 29% | 100% |
A0A1X0NGU0 | Trypanosomatidae | 36% | 100% |
A0A3S5H5V0 | Leishmania donovani | 95% | 100% |
A4H4T7 | Leishmania braziliensis | 84% | 100% |
A4HT17 | Leishmania infantum | 95% | 100% |
C9ZTQ4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 100% |
E9AL05 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |